Home Mycoplasmas including CBPP/CCPP [Adjuvant] Adjuvant
Mycoplasmas including CBPP/CCPP roadmap:
Vaccines

Research roadmap for contagious bovine pleuropneumonia (CBPP) vaccine development

Download CBPP vaccine development roadmap final

9

Adjuvant

Dependencies

Next steps

  • 4 Inactivated vaccines
  • 4A Safety
  • 4B Delivery route
  • 4C Delivery platform
  • 4D Efficacy in challenge model
  • 5 DNA/RNA vaccines
  • 5A Safety
  • 5B Delivery route
  • 5C Delivery platform
  • 5D Efficacy in challenge model
  • 6 Subunit vaccines
  • 6A Safety
  • 6B Delivery route
  • 6C Delivery platform
  • 6D Efficacy in challenge model
Adjuvant

Research Question

  1. Use adjuvants to generate an optimal immune response to different types of antigen delivery systems in cattle.

Research Gaps and Challenges

  1. While there are some guidelines on the use of different types of adjuvants, immunogenicity studies are needed.
  2. Insufficient knowledge on molecular adjuvants to skew immune responses.
  3. Lack of in vitro assays that correlate/associate with immunity to CBPP.

Solution Routes

  1. Further studies with Montanide and other adjuvants with the subunit vaccine.

Dependencies

  1. Standardized cattle breed specific laboratory challenge models that reproduce CBPP caused by natural infection or are acceptable surrogates.
  2. Identity of protective mechanisms and immune correlates of protection in vitro and in vivo.
  3. Assess ability to meet minimal and desired TPPs.
  4. Assess ability to scale-up and manufacture.

State Of the Art

  1. Experimental vaccine antigens have been identified.